Tooth Regeneration

In modern regenerative medicine, **'complete tooth regeneration'** is considered the most disruptive direction to traditional dentistry, aiming to allow patients to regrow their natural teeth. I. Core Mechanism: Awakening the 'Third Set of Teeth' Humans only replace their teeth once in a lifetime, but research has found that **'tooth buds'** lie dormant deep within the jawbone, suppressed by specific proteins in the body (like USAG-1). A team from Kyoto University in Japan developed an antibody drug (TRG035) that neutralizes this inhibitory protein, releasing the growth brake. This has already successfully induced new tooth growth in animal experiments. II. Clinical Trial Progress The therapy has advanced to human clinical trials: Initial Target: Primarily targeting patients with **congenital tooth agenesis (congenital tooth loss)** to address the issue of permanent teeth missing due to genetic factors. Future Blueprint: Aiming for market release around 2030. If the indication for congenital tooth agenesis is successful, it will be further expanded in the future to the general public who have lost teeth due to cavities, periodontal disease, or accidents. III. Advantages and Challenges Compared to traditional surgery requiring bone drilling for implants, this therapy is a drug treatment, significantly reducing surgical risks and pain. However, future challenges include precisely controlling the growth position and biting angle of new teeth, as well as assessing the responsiveness of the alveolar bone in adults who have been missing teeth for many years. If the technology becomes widespread, it will usher in a new era of biological tooth replacement for humanity.